Loader

Pathways

PathWhiz ID Pathway Meta Data

PW146635

Pw146635 View Pathway
drug action

Benziodarone Drug Metabolism Action Pathway

Homo sapiens

PW132332

Pw132332 View Pathway
metabolic

Benznidazole Drug Metabolism

Homo sapiens
Benznidazole is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Benznidazole passes through the liver and is then excreted from the body mainly through the kidney.

PW146481

Pw146481 View Pathway
drug action

Benznidazole Drug Metabolism Action Pathway

Homo sapiens

PW248089

Pw248089 View Pathway
metabolic

Benzoate degradation I

Aromatoleum aromaticum
Benzoate, an environmental pollutant, is utilized by bacteria such as Aromatoleum aromaticum to yield energy and carbon. While the precise transport mechanisms remain under research, it is proposed that benzoate is transported across the cell membrane passively or actively via transport proteins such as permeases and porins. Benzoate is then converted to benzoyl-CoA by benzoate-CoA ligase. Benzoyl-CoA then undergoes further degradation, catalyzed by enzymes like benzoyl-CoA reductase, leading to the formation of intermediate cyclohexane compounds which are ultimately converted into central metabolites that can enter the citrate cycle for further energy generation

PW248105

Pw248105 View Pathway
metabolic

Benzoate degradation II

Aromatoleum aromaticum
Benzoate, an environmental pollutant, is utilized by bacteria such as Aromatoleum aromaticum to yield energy and carbon. While the precise transport mechanisms remain under research, it is proposed that benzoate is transported across the cell membrane passively or actively via transport proteins such as permeases and porins. Benzoate is then converted to benzoyl-CoA by benzoate-CoA ligase. Benzoyl-CoA is then used for phenylalanine metabolism and processes e.g., biosynthesis of alkaloids

PW126630

Pw126630 View Pathway
drug action

Benzocaine

Homo sapiens
Benzocaine is a topical local ester anesthetic used for relief of pain and itching, it acts by preventing transmission of impulses. Its duration of action lasts for about 10 minutes, once applied it diffuses into the nerve cells it binds to sodium channels. By binding to sodium channels it blocks the influx of sodium ions stopping the cells from depolarizing and conducting a nerve impulse. Benzocaine is broken down through ester hydrolysis into its resulting metabolites such as aminobenzoic acid, acetylbenzocaine and benzocaine hydroxylamine. Some adverse side effects that an individual may experience systemic toxicity syndrome, decreased cardiovascular function, decreased central nervous system function, cardiac complications and seizures.

PW000398

Pw000398 View Pathway
drug action

Benzocaine Action Pathway

Homo sapiens
Benzocaine exerts its local anaesthetic effect by blocking voltage-gated sodium channels in peripheral neurons. Benzocaine diffuses across the neuronal plasma membrane in its uncharged base form. Once inside the cytoplasm, it is protonated and this protonated form enters and blocks the pore of the voltage-gated sodium channel from the cytoplasmic side. For this to happen, the sodium channel must first become active so that so that gating mechanism is in the open state. Therefore benzocaine preferentially inhibits neurons that are actively firing.

PW145177

Pw145177 View Pathway
drug action

Benzocaine Drug Metabolism Action Pathway

Homo sapiens

PW145541

Pw145541 View Pathway
drug action

Benzoic acid Drug Metabolism Action Pathway

Homo sapiens

PW146740

Pw146740 View Pathway
drug action

Benzoin Drug Metabolism Action Pathway

Homo sapiens